Literature DB >> 14987361

The molecular biology of Wilms tumour.

K W Brown1, K T Malik.   

Abstract

Entities:  

Year:  2001        PMID: 14987361     DOI: 10.1017/S1462399401003027

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


× No keyword cloud information.
  11 in total

Review 1.  Candidate genes and potential targets for therapeutics in Wilms' tumour.

Authors:  Christopher Blackmore; Max J Coppes; Aru Narendran
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

Review 2.  Wilms tumor--a renal stem cell malignancy?

Authors:  Naomi Pode-Shakked; Benjamin Dekel
Journal:  Pediatr Nephrol       Date:  2011-04-16       Impact factor: 3.714

3.  Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.

Authors:  Ming-Ru Chiang; Chi-Wen Kuo; Wen-Chung Wang; Tai-Cheng Hou; Chen-Yun Kuo; Meng-Yao Lu; Yen-Chein Lai
Journal:  Pathol Oncol Res       Date:  2019-01-23       Impact factor: 3.201

4.  Correlations between histological characterizations and methylation statuses of tumour suppressor genes in Wilms' tumours.

Authors:  Yen-Chein Lai; Meng-Yao Lu; Wen-Chung Wang; Tai-Cheng Hou; Chen-Yun Kuo
Journal:  Int J Exp Pathol       Date:  2022-04-18       Impact factor: 2.793

5.  Teratogen-induced, dietary and genetic models of congenital diaphragmatic hernia share a common mechanism of pathogenesis.

Authors:  Robin D Clugston; Jürgen Klattig; Chistoph Englert; Margaret Clagett-Dame; Jelena Martinovic; Alexandra Benachi; John J Greer
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

6.  Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.

Authors:  Peter Paschka; Guido Marcucci; Amy S Ruppert; Susan P Whitman; Krzysztof Mrózek; Kati Maharry; Christian Langer; Claudia D Baldus; Weiqiang Zhao; Bayard L Powell; Maria R Baer; Andrew J Carroll; Michael A Caligiuri; Jonathan E Kolitz; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2008-06-16       Impact factor: 44.544

7.  WT1 represses HOX gene expression in the regulation of gynaecologic tumour histologic type.

Authors:  Vaagn Andikyan; Hugh S Taylor
Journal:  J Cell Mol Med       Date:  2009 Nov-Dec       Impact factor: 5.310

8.  In silico regulatory analysis for exploring human disease progression.

Authors:  Dustin T Holloway; Mark Kon; Charles DeLisi
Journal:  Biol Direct       Date:  2008-06-18       Impact factor: 4.540

9.  HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients.

Authors:  Lourdes Hontecillas-Prieto; Daniel J García-Domínguez; Rosa García-Mejías; Gema L Ramírez-Villar; Carmen Sáez; Enrique de Álava
Journal:  Oncotarget       Date:  2017-12-14

10.  Regulation of retinoic acid synthetic enzymes by WT1 and HDAC inhibitors in 293 cells.

Authors:  Yifan Li; Lei Wang; Weipeng Ai; Nianhui He; Lin Zhang; Jihui Du; Yong Wang; Xingjian Mao; Junqi Ren; Dan Xu; Bei Zhou; Rong Li; Liwen Mai
Journal:  Int J Mol Med       Date:  2017-07-03       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.